• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

确保临床实验室改进修正案(CLIA)能力验证测试要求的质量所需的胆固醇操作过程规范。

Cholesterol operational process specifications for assuring the quality required by CLIA proficiency testing.

作者信息

Westgard J O, Wiebe D A

机构信息

Department of Pathology and Laboratory Medicine, Medical School, University of Wisconsin, Madison 53792.

出版信息

Clin Chem. 1991 Nov;37(11):1938-44.

PMID:1934469
Abstract

Current U.S. governmental regulations and requirements for the quality of laboratory tests do not provide a consistent form, comparable numbers, or practical specifications for the routine operation of laboratory testing processes. For cholesterol, as an example, the Health Care Financing Administration provides an analytical performance criterion for proficiency testing to enforce the Clinical Laboratory Improvement Act (CLIA), whereas the U.S. National Cholesterol Education Program (NCEP) provides clinical guidelines for test interpretation, as well as analytical goals for imprecision and inaccuracy. Routine operating process specifications for imprecision, inaccuracy, and quality control can be derived from the analytical and clinical requirements for quality. Use of an analytical "total error" model and a clinical "decision interval" model provides logically consistent and numerically comparable specifications. Studies with these coherent models indicate that a cholesterol testing process properly planned to satisfy the CLIA analytical requirement will also satisfy the NCEP clinical requirement. To provide 90% assurance of detecting systematic shifts of a magnitude that would cause the CLIA analytical requirement to be exceeded, the operational specifications for a cholesterol testing process are an allowable CV of less than or equal to 2%, an allowable bias of less than or equal to 1%, and a control procedure with two measurements per run interpreted by 1(3)s, 1(2.5)s, or 1(3)s/2(2)s/R4s control rules.

摘要

美国现行政府对实验室检测质量的法规和要求,并未为实验室检测过程的常规操作提供统一的形式、可比较的数据或实用的规范。以胆固醇检测为例,医疗保健财务管理局为能力验证提供分析性能标准,以执行《临床实验室改进法案》(CLIA),而美国国家胆固醇教育计划(NCEP)则提供检测结果解读的临床指南,以及不精密度和不准确的分析目标。不精密度、不准确和质量控制的常规操作过程规范可从质量的分析和临床要求推导得出。使用分析“总误差”模型和临床“决策区间”模型可提供逻辑一致且数值可比的规范。采用这些连贯模型的研究表明,一个经过合理规划以满足CLIA分析要求的胆固醇检测过程,也将满足NCEP临床要求。为提供90%的把握度以检测到可能导致超出CLIA分析要求的系统性偏移,胆固醇检测过程的操作规范为:允许变异系数(CV)小于或等于2%,允许偏差小于或等于1%,以及采用每次运行两次测量的控制程序,并根据1(3)s、1(2.5)s或1(3)s/2(2)s/R4s控制规则进行解读。

相似文献

1
Cholesterol operational process specifications for assuring the quality required by CLIA proficiency testing.确保临床实验室改进修正案(CLIA)能力验证测试要求的质量所需的胆固醇操作过程规范。
Clin Chem. 1991 Nov;37(11):1938-44.
2
Laboratory process specifications for assuring quality in the U.S. National Cholesterol Education Program.
Clin Chem. 1991 May;37(5):656-61.
3
European specifications for imprecision and inaccuracy compared with operating specifications that assure the quality required by US CLIA proficiency-testing criteria.与确保符合美国临床实验室改进修正案(CLIA)能力验证标准所要求质量的操作规范相比,欧洲的不精密度和不准确度规范。
Clin Chem. 1994 Jul;40(7 Pt 1):1228-32.
4
Cholesterol--a model system to relate medical needs with analytical performance.胆固醇——将医学需求与分析性能相关联的模型系统。
Clin Chem. 1993 Jul;39(7):1504-12; discussion 1512-3.
5
Charts of operational process specifications ("OPSpecs charts") for assessing the precision, accuracy, and quality control needed to satisfy proficiency testing performance criteria.用于评估满足能力验证性能标准所需的精密度、准确度和质量控制的操作过程规范图表(“操作规范图表”)。
Clin Chem. 1992 Jul;38(7):1226-33; discussion 1245-50.
6
Assuring analytical quality through process planning and quality control.通过流程规划和质量控制确保分析质量。
Arch Pathol Lab Med. 1992 Jul;116(7):765-9.
7
Allowable imprecision for laboratory tests based on clinical and analytical test outcome criteria.
Clin Chem. 1994 Oct;40(10):1909-14.
8
Laboratory precision performance: state of the art versus operating specifications that assure the analytical quality required by clinical laboratory improvement amendments proficiency testing.实验室精密性能:最新技术水平与确保临床实验室改进修正案能力验证所需分析质量的操作规范。
Arch Pathol Lab Med. 1996 Jul;120(7):621-5.
9
Limitations of proficiency testing under CLIA '67.《1967年临床实验室改进修正案》下能力验证的局限性。
Clin Chem. 1992 Jul;38(7):1237-44; discussion 1245-50.
10
Comparison of NCEP performance specifications for triglycerides, HDL-, and LDL-cholesterol with operating specifications based on NCEP clinical and analytical goals.基于美国国家胆固醇教育计划(NCEP)临床和分析目标的甘油三酯、高密度脂蛋白胆固醇和低密度脂蛋白胆固醇的NCEP性能规范与操作规范的比较。
Clin Chem. 1997 Nov;43(11):2164-8.

引用本文的文献

1
Quality leadership and quality control.质量领导力与质量控制。
Clin Biochem Rev. 2003 Aug;24(3):81-93.